Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
MetLife, Inc.

MetLife, Inc. (MET) Stock Overview

Explore MetLife, Inc.’s financial performance, market position, analyst ratings, and future outlook.

MET●NYSE
Financial ServicesInsurance - Life
$97.04
$0.31(0.32%)
U.S. Market opens in 46h 30m

MetLife, Inc. (MET)

Meyka AI Score

Z

Key Financials

Market Cap62.4B
P/E Ratio18.48
EPS (TTM)$9.77
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$98.38
3 Months$110.67
1 Year Target$90.65

MET Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of MetLife, Inc. (NYSE: MET) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, MetLife, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MET on the NYSE shows an RSI of 52.71, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $90.65 for the NYSE listing.

Key metrics behind MetLife, Inc.'s NYSE-traded stock include a P/E ratio of 18.48 and a market capitalization of 62.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of MET on the NYSE.

Price Performance (NYSE: MET)

1-Day Change
-0.32%
5-Day Change
-0.98%
1-Month Change
0.32%
3-Month Change
13.39%
6-Month Change
41.46%
Year-to-Date (YTD) Change
22.93%
1-Year Change
22.73%
3-Year Change
46.37%
5-Year Change
63.61%
All-Time (Max) Change
638.51%

Contact Information

https://www.metlife.com
212 578 9500
200 Park Avenue, New York City, NY, 10166-0188

Company Facts

460,000 Employees
IPO DateApr 5, 2000
CountryUS
Actively Trading

Frequently Asked Questions